The rush to market Cannabidiol-based personal care products may have hit a speed bump. The US FDA notes that it has approved only one CBD product, a prescription drug product to treat two rare, severe forms of epilepsy. Furthermore, the FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason. According to the Agency, some CBD products are being marketed with unproven medical claims and are of unknown quality. ...